How much funding has Ansa Biotechnologies raised?

Ansa Biotechnologies has raised $131.6M in total funding, most recently a Series B round.

Who are Ansa Biotechnologies's investors?

Ansa Biotechnologies's investors include Fifty Years, Horizons Ventures, Cerberus Ventures, Northpond Ventures, Blue Water Life Science Advisors, Altitude Life Science Ventures.

When was Ansa Biotechnologies founded?

Ansa Biotechnologies was founded in 2018.

Where is Ansa Biotechnologies headquartered?

Ansa Biotechnologies is headquartered in Emeryville, California, United States.

What industry is Ansa Biotechnologies in?

Ansa Biotechnologies operates in Biotech, Healthcare, Synthetic Biology.

How many employees does Ansa Biotechnologies have?

Ansa Biotechnologies has 51-200 employees.

Ansa Biotechnologies

formerly Ansa

Next-generation DNA synthesis using enzymes

Emeryville, United States · Founded 2018 · $131.6M raised

Biotech

Healthcare

Synthetic Biology

YC W20

Headquarters: Emeryville, California
Employees: 51–200
Founded: 2018
Business Model: B2B

Website: ansabio.com
Total Funding: $131.6M
Last Round: $54.4M Series BOct 2025
Rounds: 4

About

Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.

Summary

Ansa Biotechnologies is a Biotech company based in Emeryville, United States, founded in 2018. It has raised $131.6M in total across 4 rounds, most recently a $54.4M Series B round in Oct 2025. Investors include Fifty Years, Horizons Ventures and Cerberus Ventures.

LinkedIn X (Twitter)